73 related articles for article (PubMed ID: 1451552)
1. Comparison of serum bactericidal activity of 4 fluoroquinolones in healthy volunteers.
Wang R; Liu YN; Zhao HZ; Sun XD
Chin Med J (Engl); 1992 Jun; 105(6):500-5. PubMed ID: 1451552
[TBL] [Abstract][Full Text] [Related]
2. Correlation of in vitro activities of the fluoroquinolones to their in vivo efficacies.
Fernandes PB; Swanson RN
Drugs Exp Clin Res; 1988; 14(6):375-8. PubMed ID: 3145851
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of E-4868, a new fluoroquinolone with a 7-azetidin ring, compared with ciprofloxacin, ofloxacin and fleroxacin.
Mirelis B; Navarro F; Miró E; Coll R; Xicota MA; Prats G
Drugs Exp Clin Res; 1995; 21(4):129-38. PubMed ID: 8529525
[TBL] [Abstract][Full Text] [Related]
4. Comparative antimicrobial activity of lomefloxacin, norfloxacin, ofloxacin, ciprofloxacin and enoxacin against > 500 bacterial isolates.
Ismaeel NA; Tayeb OS
Microbios; 1993; 74(300):147-54. PubMed ID: 8396196
[TBL] [Abstract][Full Text] [Related]
5. Overview of the fluoroquinolone antibiotics.
Just PM
Pharmacotherapy; 1993; 13(2 Pt 2):4S-17S. PubMed ID: 8386356
[TBL] [Abstract][Full Text] [Related]
6. [In vitro antibacterial activity of a new fluoroquinolone, enoxacin against hospital bacteria and regression curve].
Soussy CJ; Cluzel M; Meyran M
Pathol Biol (Paris); 1995 Apr; 43(4):274-80. PubMed ID: 7567114
[TBL] [Abstract][Full Text] [Related]
7. A multicenter study on the comparative in vitro activity of fleroxacin and three other quinolones: an interim report from 27 centers.
Beskid G; Prosser BL
Am J Med; 1993 Mar; 94(3A):2S-8S. PubMed ID: 8383919
[TBL] [Abstract][Full Text] [Related]
8. Concentrations in plasma, urinary excretion and bactericidal activity of levofloxacin (500 mg) versus ciprofloxacin (500 mg) in healthy volunteers receiving a single oral dose.
Wagenlehner FM; Kinzig-Schippers M; Sörgel F; Weidner W; Naber KG
Int J Antimicrob Agents; 2006 Dec; 28(6):551-9. PubMed ID: 17101261
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of lomefloxacin, a new difluorinated quinolone, against urinary bacterial isolates: comparison with enoxacin and ofloxacin.
Azadian BS; Talboys CA; Roberts AP
J Chemother; 1989 Jul; 1(4 Suppl):176-7. PubMed ID: 16312357
[No Abstract] [Full Text] [Related]
10. Therapeutic effect of the quinolone prodrug prulifloxacin against experimental urinary tract infections in mice.
Tomii Y; Ozaki M; Matsuda M; Honmura T; Nishimura I; Yamaguchi R; Adachi T; Okawa Y; Nishino T
Arzneimittelforschung; 1996 Dec; 46(12):1169-73. PubMed ID: 9006794
[TBL] [Abstract][Full Text] [Related]
11. [In vitro antimycobacterial activity of a new quinolone, NM394].
Tomioka H; Sato K; Saito H
Kekkaku; 1993 Aug; 68(8):517-20. PubMed ID: 8397311
[TBL] [Abstract][Full Text] [Related]
12. Anti-staphylococcal activity of temafloxacin, ciprofloxacin, ofloxacin and enoxacin.
Barry AL; Fuchs PC
J Antimicrob Chemother; 1991 Nov; 28(5):695-9. PubMed ID: 1663929
[TBL] [Abstract][Full Text] [Related]
13. [Comparison of in vitro antimicrobial activities of ofloxacin, levofloxacin, ciprofloxacin, and sparfloxacin against various mycobacteria].
Kawahara S; Tada A; Nagare H
Kekkaku; 2001 Apr; 76(4):357-62. PubMed ID: 11398326
[TBL] [Abstract][Full Text] [Related]
14. Comparison of inhibitory effects of new quinolones on drug metabolizing activity in the liver.
Nakanishi S; Okuno H
Jpn J Pharmacol; 1990 May; 53(1):81-96. PubMed ID: 2352379
[TBL] [Abstract][Full Text] [Related]
15. [Determination of antimycobacterial activities of fluoroquinolones against clinical isolates of Mycobacterium tuberculosis: comparative determination with egg-based Ogawa and agar-based Middlebrook 7H10 media].
Yamane N; Chilima BZ; Tosaka M; Okazawa Y; Tanno K
Kekkaku; 1996 Aug; 71(8):453-8. PubMed ID: 8831190
[TBL] [Abstract][Full Text] [Related]
16. [Phototoxicity studies of pazufloxacin mesilate, a novel parenteral quinolone antimicrobial agent--in vitro and in vivo studies].
Nagasawa M; Nakamura S; Miyazaki M; Nojima Y; Hayakawa H; Kawamura Y
Jpn J Antibiot; 2002 Jun; 55(3):259-69. PubMed ID: 12199110
[TBL] [Abstract][Full Text] [Related]
17. [In vitro antimicrobial activities of new quinolone antibiotics against Mycoplasma pneumoniae].
Gohara Y; Arai S; Kuwano K; Kawashima T; Matsu-Ura I
Nihon Saikingaku Zasshi; 1992 Mar; 47(2):387-93. PubMed ID: 1318981
[TBL] [Abstract][Full Text] [Related]
18. Comparative antimycobacterial activities of the newly synthesized quinolone AM-1155, sparfloxacin, and ofloxacin.
Tomioka H; Saito H; Sato K
Antimicrob Agents Chemother; 1993 Jun; 37(6):1259-63. PubMed ID: 8392307
[TBL] [Abstract][Full Text] [Related]
19. [Clinical efficacy of ciprofloxacin and ofloxacin].
Jiang SC; Wang XF; Miao JZ
Zhonghua Nei Ke Za Zhi; 1994 Jul; 33(7):444-8. PubMed ID: 7867437
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and serum bactericidal activities of quinolones in combination with clindamycin, metronidazole, and ornidazole.
Boeckh M; Lode H; Deppermann KM; Grineisen S; Shokry F; Held R; Wernicke K; Koeppe P; Wagner J; Krasemann C
Antimicrob Agents Chemother; 1990 Dec; 34(12):2407-14. PubMed ID: 2088195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
